Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage IIIC2 Cervical Cancer FIGO 2018”

5 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 5 of 5 results

Not applicableActive Not RecruitingNCT04574635
What this trial is testing

Human Papilloma Virus (HPV) Circulating Tumor DNA (ctDNA) in Cervical Cancer

Who this might be right for
Cervical Adenosquamous CarcinomaCervical Squamous Cell Carcinoma, Not Otherwise SpecifiedInfiltrating Cervical Carcinoma+24 more
Mayo Clinic 18
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07368985
What this trial is testing

Pembrolizumab and Lenvatinib in Patients With High Risk Locally Advanced Cervix Cancer

Who this might be right for
Cervical Cancer by FIGO Stage 2018Squamous Cell Carcinoma FIGO 2018 Stage IIIA, IIIB, IIIC1-IIIC2Adenocarcinoma or Adeno-squamous Carcinoma Stage IB3-IIIC2
Prof. Dr. Remi A. Nout 87
Large-scale testing (Phase 3)Looking for participantsNCT07061977
What this trial is testing

Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer

Who this might be right for
Locally Advanced Cervical AdenocarcinomaLocally Advanced Cervical Adenosquamous CarcinomaLocally Advanced Cervical Squamous Cell Carcinoma+5 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Active Not RecruitingNCT04580771
What this trial is testing

A Vaccine (PDS0101) and Chemoradiation for the Treatment of Stage IB3-IVA Cervical Cancer, the IMMUNOCERV Trial

Who this might be right for
Locally Advanced Cervical Squamous Cell Carcinoma, Not Otherwise SpecifiedStage IB3 Cervical Cancer FIGO 2018Stage II Cervical Cancer FIGO 2018+11 more
M.D. Anderson Cancer Center 22
Not applicableWithdrawnNCT05093712
What this trial is testing

Patient-Informed Educational Intervention for the Improvement of Cervical Cancer Literacy

Who this might be right for
Stage IB Cervical Cancer FIGO 2018Stage IB1 Cervical Cancer FIGO 2018Stage IB2 Cervical Cancer FIGO 2018+13 more
M.D. Anderson Cancer Center
336